Myriad Genetics (MYGN) Announces Thomas P. Slavin, M.D., Named Chief Medical Officer
Go back to Myriad Genetics (MYGN) Announces Thomas P. Slavin, M.D., Named Chief Medical Officer| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 6.10 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.10 | 52 Week High | $45.34 | |||
| Open | $6.10 | 52 Week Low | $15.92 | |||
| Day High | $6.10 | P/E | 2.62 | |||
| Day Low | $6.10 | EPS | $2.33 | |||
| Volume | 2,030 | |||||
